To better understand the clinical applicability of cfDNA assays, we developed a hybridization capture-based panel targeting the most common translocation partners in two pediatric cancers, specifically EWSR1 for Ewing sarcoma and FOXO1 in ARMS5. The gene discussed is FOXO1; the disease is cancer.